Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > NanoImaging Services Receives $1.5 Million in Venture Funding from Merck Capital Ventures

Abstract:
Funds to be used for expansion of service laboratory;
NanoImaging provides high-resolution 3D imaging of large molecule biopharmaceuticals

NanoImaging Services Receives $1.5 Million in Venture Funding from Merck Capital Ventures

San Diego, CA | Posted on March 22nd, 2008

NanoImaging Services, Inc., the leading provider of high-resolution, three-dimensional (3D) transmission electron microscope (TEM) imaging services to manufacturers of large molecule biopharmaceuticals, announced today that it has completed a round of financing led by Merck Capital Ventures, LLC. The $1.5 million investment will be used to expand the company's service laboratory. NanoImaging Services, currently located in Northern San Diego, will relocate to a larger facility in La Jolla, Calif. next month.

"Advanced TEM imaging allows biopharmaceutical manufacturers to actually see the complex macromolecular structures they create, in three dimensions, with resolution as high as one nanometer," said Clint Potter, NanoImaging's CEO. "It provides powerful visual support for structural characterization and validation throughout the drug development pipeline—promising to shorten development cycles and improve confidence at every stage from discovery, through development and regulatory review, and into long-term quality control and manufacturing process improvement."

"NanoImaging Services has established a unique combination of advanced technology and world-class expertise in large molecule visualization and analysis," said Per Lofberg, President and CEO of Merck Capital Ventures. "With its straightforward commercial service model, and the potential to accelerate candidate development, the company is well-positioned for leadership in supporting the pharmaceutical industry in the field of large molecule biologics."

NanoImaging Services offers a range of services including simple visual inspection; statistical characterization; antibody/labeling experiments; and nanometer-scale, 3D reconstruction. Advanced instrumentation within the laboratory includes a state-of-art Tecnai™ TEM and Vitrobot™ cryo-preservation system from FEI. Advanced cryo techniques preserve delicate biological structures in their native, fully-hydrated state. Clint Potter and Bridget Carragher, NanoImaging's founders, both hold faculty appointments at The Scripps Research Institute, La Jolla, Calif., where they jointly manage the Automated Molecular Imaging Research Group. They have published extensively on TEM technology and the science it enables.

####

About NanoImaging Services, Inc.
NanoImaging Services, Inc. provides transmission electron microscope imaging services to the pharmaceutical, biotechnology and nanotechnology industries, and specializes in the characterization of large biological molecules used in biopharmaceuticals such as vaccines, antibodies, cytokines, hormones and gene therapies. In contrast to conventional (small molecule) drugs, biopharmaceuticals are typically protein-based and manufactured in controlled, modified, biological systems. Their complexity and similarity to naturally occurring compounds makes a detailed understanding of their structure, and its relationship to their safety and efficacy, essential in their development and approval. Biopharmaceuticals represent an important and rapidly-growing segment of the pharmaceutical industry. For more information, visit www.nanoimagingservices.com.

About Merck Capital Ventures
Merck Capital Ventures (MCV) is a subsidiary of Merck & Co., Inc. MCV seeks to invest capital in emerging businesses in areas related to the commercialization, distribution and delivery of pharmaceuticals and related health care services. The focus of MCV is to invest in technologies that accelerate innovation related to the pharmaceutical business and other sectors of health care delivery.

For more information, please click here

Contacts:
Clint Potter
NanoImaging Services, Inc.
888-675-8261


Gary Lubin
Merck & Co.
908-423-3665


Sandy Fewkes
MindWrite Communications, Inc.
408-224-4024

Copyright © NanoImaging Services, Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Researchers develop artificial building blocks of life March 8th, 2024

How surface roughness influences the adhesion of soft materials: Research team discovers universal mechanism that leads to adhesion hysteresis in soft materials March 8th, 2024

Two-dimensional bimetallic selenium-containing metal-organic frameworks and their calcinated derivatives as electrocatalysts for overall water splitting March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

Imaging

Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024

First direct imaging of small noble gas clusters at room temperature: Novel opportunities in quantum technology and condensed matter physics opened by noble gas atoms confined between graphene layers January 12th, 2024

The USTC realizes In situ electron paramagnetic resonance spectroscopy using single nanodiamond sensors November 3rd, 2023

Observation of left and right at nanoscale with optical force October 6th, 2023

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

Graphene Flagship start-up Bedimensional closes a second €10 million investment round February 10th, 2023

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021

180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor February 22nd, 2021

Announcements

What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024

Tools

First direct imaging of small noble gas clusters at room temperature: Novel opportunities in quantum technology and condensed matter physics opened by noble gas atoms confined between graphene layers January 12th, 2024

New laser setup probes metamaterial structures with ultrafast pulses: The technique could speed up the development of acoustic lenses, impact-resistant films, and other futuristic materials November 17th, 2023

Ferroelectrically modulate the Fermi level of graphene oxide to enhance SERS response November 3rd, 2023

The USTC realizes In situ electron paramagnetic resonance spectroscopy using single nanodiamond sensors November 3rd, 2023

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project